News & Videos - USANA HEALTH SCIENCES INC. - English

USANA Health Sciences, Inc. (NYSE: USNA) today announced financial results for its fiscal first quarter ended March 29, 2025. Key Financial Results First Quarter 2025 vs. First Quarter 2024 Net sales of $250 million versus $228 million, representing year-over-year growth of 10% and 12% in constant currency. Net earnings of $9.4 million versus $16.5 million. Diluted EPS of $0.49 as compared with $0.86. Adjusted diluted EPS (1) of $0.73 as compared with $0.86. Adjusted EBITDA (2) of $30 million...

USANA Health Sciences, Inc. (NYSE:USNA) today announced that first quarter 2025 results will be released after the close of market on Tuesday, April 22, 2025. Shortly following the issuance of the Company’s earnings release, the Company will post its Management Commentary document on the Company’s Investor Relations website ( http://ir.usana.com ) under the News/Events section. USANA will hold a conference call to discuss this announcement with analysts and institutional investors the...

USANA Health Sciences, Inc. (NYSE: USNA) (the “Company”) today announced financial results for its fiscal fourth quarter and fiscal year ended December 28, 2024. The Company completed the acquisition of a 78.8% controlling ownership stake of Hiya Health Products, LLC (“Hiya”) on December 23, 2024. Consequently, the Company’s fourth quarter and fiscal year 2024 include the effect of less than a week of Hiya’s operating results, which were not significant to the Company’s...

USANA Health Sciences, Inc. (NYSE:USNA) today announced that fourth quarter and fiscal year 2024 results will be released after the close of market on Tuesday, February 25, 2025. Shortly following the issuance of the Company’s earnings release, the Company will post its Management Commentary document on the Company’s Investor Relations website ( http://ir.usana.com ) under the News/Events section. USANA will hold a conference call to discuss this announcement with analysts and institutional...

USANA Health Sciences, Inc. (NYSE:USNA), a leading developer and manufacturer of high-quality nutritional supplements, healthy foods and personal care products, today announced that Doug Hekking, Chief Financial Officer, will participate in a fireside chat and host one-on-one meetings with investors at the ICR Conference in Orlando, FL on January 13-14, 2025. The fireside chat will begin at 8:00 AM ET on January 13, 2025. A live audio webcast of the fireside chat will be available on USANA’s...

USANA Health Sciences, Inc. (NYSE: USNA) (the “Company,” “USANA”), today announced its acquisition of a 78.8% controlling ownership stake in Hiya Health Products, LLC (“Hiya”), a leading direct-to-consumer provider of high-quality children’s health & wellness products. The $205 million cash transaction closed on December 23, 2024 and is anticipated to be accretive to USANA’s 2025 adjusted EBITDA. For the last twelve months ended September 30, 2024 (unaudited), Hiya generated net...

USANA Health Sciences, Inc. (NYSE: USNA) today announced financial results for its fiscal second quarter ended July 1, 2023. Key Financial & Operating Results Second quarter net sales were $238 million versus $264 million during the second quarter of 2022. Second quarter diluted EPS was $0.89 as compared with $1.00 during the second quarter of 2022. Fiscal 2023 net sales and diluted EPS guidance updated to $900 to $950 million and $2.65 to $3.30, respectively, from $875 million to $950 million...

USANA Health Sciences, Inc. (NYSE:USNA) today announced that second quarter results will be released after the close of market on Tuesday, July 25, 2023. Shortly following the issuance of the Company’s earnings release, the Company will post its Management Commentary document on the Company’s Investor Relations website ( http://ir.usana.com ) under the News/Events section. USANA will hold a conference call to discuss this announcement with analysts and institutional investors the following...

USANA Health Sciences, Inc. (NYSE: USNA) today announced its plans to expand into India in the second half of 2023. Expansion into India increases the Company’s global footprint to 25 markets. “USANA’s expansion into India is our first new market in five years and provides an exciting and gratifying opportunity to introduce USANA’s world class health and wellness products to a new country, culture and demographic,” said Jim Brown, President. “We have spent several years of extensive...

USANA Health Sciences, Inc. (NYSE: USNA) today announced financial results for its fiscal first quarter ended April 1, 2023. Key Financial & Operating Results First quarter net sales were $248 million versus $228 million for the fourth quarter of 2022 and $273 million during the first quarter of 2022. First quarter diluted EPS was $0.95 as compared with $0.66 for the fourth quarter of 2022 and $1.15 during the first quarter of 2022. Generated $13 million of operating cash flow during the...

USANA Health Sciences, Inc. (NYSE:USNA) today announced that first quarter results will be released after the close of market on Tuesday, April 25, 2023. Shortly following the issuance of the Company’s earnings release, the Company will post its Management Commentary document on the Company’s Investor Relations website ( http://ir.usana.com ) under the News/Events section. USANA will hold a conference call to discuss this announcement with analysts and institutional investors the following...

USANA Health Sciences, Inc. (NYSE:USNA), a leading developer and manufacturer of high-quality nutritional supplements, healthy foods and personal care products, today announced that Doug Hekking, Chief Financial Officer, is scheduled to participate in upcoming investor conferences. Details for each event are as follows: 35 th Annual Roth Conference Monday, March 13, 2023 1x1 Investor Meetings Dana Point, CA D.A. Davidson Consumer Growth Conference Tuesday, March 21, 2023 1x1 Investor Meetings...

USANA Health Sciences, Inc. (NYSE: USNA) today announced financial results for its fiscal fourth quarter and full year ended December 31, 2022. Key Financial & Operating Results Fourth quarter net sales were $228 million versus $267 million during the prior-year period. Fourth quarter diluted EPS was $0.66 as compared with $1.03 during Q4 2021. Fiscal year 2022 net sales were $999 million as compared with $1,186 million during fiscal year 2021. Fiscal year 2022 diluted EPS totaled $3.59 versus...

USANA Health Sciences, Inc. (NYSE: USNA) today announced preliminary fiscal year 2022 results and initial guidance for fiscal year 2023 ahead of its presentation at the 25 th Annual ICR Conference. The Company currently anticipates fiscal year 2022 net sales of approximately $995 million and diluted earnings per share of approximately $3.65. The Company’s most recently issued fiscal year 2022 guidance anticipated net sales between $955 and $975 million and diluted earnings per share between...

USANA Health Sciences, Inc. (NYSE:USNA), a leading developer and manufacturer of high-quality nutritional supplements, healthy foods and personal care products, today announced that Doug Hekking, Chief Financial Officer, will present and host one-on-one meetings with investors at the ICR Conference in Orlando, FL on January 9-10, 2023. The presentation will begin at 3:30PM ET on January 10, 2023. A live audio webcast of the presentation will be available on USANA’s website at...

USANA Health Sciences Named a Best Company to Work For in Utah PR Newswire SALT LAKE CITY, Dec. 8, 2022 Utah Business Magazine Applauds USANA's Culture SALT LAKE CITY , Dec. 8, 2022 /PRNewswire/ -- USANA Health Sciences, Inc., a global leader in nutrition, was recently named a Best Company to Work For by Utah Business magazine . It's the second time this year USANA has been named a top employer—also being awarded a Best Place to Work in Direct Selling by Direct Selling News in April. This...

USANA Health Sciences, Inc. (NYSE:USNA), a leading developer and manufacturer of high-quality nutritional supplements, healthy foods and personal care products, today announced that Doug Hekking, Chief Financial Officer, will present and host one-on-one meetings with investors at the Sidoti December Virtual Investor Conference, taking place on December 7-8, 2022. The presentation will begin at 12:15 PM ET on December 7, 2022 and can be accessed live here:...

USANA Health Sciences, Inc. (NYSE: USNA) today announced the acquisition of two companies—Rise Bar and Oola. These emerging companies share USANA’s health and wellness focus while offering distinct channels or products. Rise Bar manufactures and sells high-quality protein bars that are formulated to help customers achieve their health goals through clean and simple ingredients. Oola is an emerging direct selling company that offers a personal development framework that helps individuals...

USANA Health Sciences, Inc. (NYSE: USNA) today announced financial results for its fiscal third quarter ended October 1, 2022. Key Financial & Operating Results Third quarter net sales were $233 million as compared with $274 million during the third quarter of the prior year. Third quarter diluted EPS totaled $0.78 versus $1.36 during the third quarter of 2021. Company revises fiscal 2022 net sales and diluted EPS outlook to $955 million to $975 million and $3.15 to $3.40, respectively. Q3 2022...

USANA Health Sciences, Inc. (NYSE:USNA) today announced that third quarter results will be released after the close of market on Tuesday, October 25, 2022. Shortly following the issuance of the Company’s earnings release, the Company will post its Management Commentary document on the Company’s website ( http://ir.usana.com ) under the Investor Relations section of the site. USANA will hold a conference call to discuss this announcement with analysts and institutional investors the following...